From: Abnormal arginine synthesis confers worse prognosis in patients with middle third gastric cancer
Number | Name | Formula | MZ | RT | T vs. N | Middle vs. Upper/Lower | |||
---|---|---|---|---|---|---|---|---|---|
FC | VIP | FC | VIP | ||||||
1 | Nicotinate D-ribonucleoside | C11H14NO6 | 256.0819 | 115.2 | 5.94 | 2.36 | 3.13 | 2.27 | |
2 | Phenylacetylglutamine | C13H16N2O4 | 265.118 | 456 | 0.07 | 2.17 | 10 | 1.69 | |
3 | (5Z,9E,14Z)-(8xi,11R,12 S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoic acid | C20H32O4 | 317.2122 | 813.1 | 1.64 | 1.78 | 0.64 | 1.72 | |
4 | (13E)-11a-Hydroxy-9,15-dioxoprost-13-enoic acid | C20H32O5 | 353.2306 | 710.1 | 0.2 | 1.70 | 1.75 | 1.90 | |
5 | N-Acetylneuraminic acid | C11H19NO9 | 292.1025 | 92 | 31.63 | 1.63 | 27.47 | 2.27 | |
6 | 1-Arachidonoylglycerol | C23H38O4 | 361.2727 | 837.6 | 5.24 | 1.57 | 3.33 | 1.66 | |
7 | L-Glutamic acid | C5H9NO4 | 146.043 | 78.8 | 2.72 | 1.47 | 2.74 | 2.05 | |
8 | Indoleglycerol phosphate | C11H14NO6P | 288.0742 | 90.8 | 1.92 | 1.38 | 2.34 | 2.15 | |
9 | Prostaglandin H2 | C20H32O5 | 351.2179 | 594.3 | 3.41 | 1.30 | 3.75 | 1.73 | |
10 | Triethyl citrate | C12H20O7 | 277.128 | 714.8 | 2.53 | 1.27 | 3.13 | 1.44 | |
11 | Alpha-Linolenic acid | C18H30O2 | 279.2316 | 815.7 | 2.54 | 1.25 | 3.31 | 1.94 | |
12 | Guanosine | C10H13N5O5 | 282.0844 | 198.6 | 0.66 | 1.21 | 0.38 | 2.32 | |
13 | Propionylcarnitine | C10H19NO4 | 218.1388 | 218.6 | 1.56 | 1.03 | 1.88 | 2.68 | |
14 | Argininosuccinic acid | C10H18N4O6 | 291.129 | 89.1 | 2.91 | 1.00 | 5.06 | 2.49 | |
15 | Glycinexylidide | C10H14N2O | 179.1179 | 408.1 | 1.44 | 1.00 | 2.18 | 2.52 |